Year (Y) | Study group | SAC treated | SAC total | Mean % SAC treateda | Total population treated | Total population eligible for treatment | % total population treated |
---|---|---|---|---|---|---|---|
Y1 | A1 | 16,563 | 20,267 | 82 | Â | Â | Â |
A2 | 18,986 | 18,809 | 101 | Â | Â | Â | |
B1 | 20,382 | 24,670 | 83 | Â | Â | Â | |
B2 | 25,281 | 30,373 | 83 | Â | Â | Â | |
C1 | 22,479 | 17,598 | 128 | 43,600 | 58,648 | 74 | |
C2 | 26,373 | 25,133 | 105 | 57,058 | 83,772 | 68 | |
Y2 | A1 | 15,053 | 13,425 | 112 | Â | Â | Â |
A2 | 13,553 | 14,309 | 95 | Â | Â | Â | |
B1 | 19,322 | 17,378 | 111 | Â | Â | Â | |
B2 | 16,345 | 17,227 | 95 | Â | Â | Â | |
C1 | 23,512 | 18,123 | 130 | 47,031 | 60,410 | 78 | |
C2 | 33,735 | 25,883 | 130 | 66,671 | 86,287 | 77 | |
Y3 Treatment 1 | A1 | 23,281 | 23,021 | 101 | Â | Â | Â |
A2 | 25,174 | 23,586 | 107 | Â | Â | Â | |
B1 | 28,406 | 22,999 | 124 | Â | Â | Â | |
B2 | 33,231 | 27,781 | 120 | Â | Â | Â | |
C1 | 26,306 | 19,663 | 134 | 51,598 | 52,434 | 98 | |
C2 | 39,311 | 24,415 | 161 | 74,558 | 65,106 | 115 | |
Y3 Treatment 2 | A1 | 0 | 23,021 | Â | Â | Â | Â |
A2 | 28,203 | 23,586 | 120 | Â | Â | Â | |
B1 | 0 | 22,999 | Â | Â | Â | Â | |
B2 | 25,274 | 27,781 | 91 | Â | Â | Â | |
C1 | 0 | 19,663 | Â | Â | 52,434 | Â | |
C2 | 33,003 | 24,415 | 135 | 61,182 | 65,106 | 94 | |
Y4 Treatment 1 | A1 | 20,708 | 25,368 | 82 | Â | Â | Â |
A2 | 18,178 | 21,528 | 85 | Â | Â | Â | |
B1 | 27,316 | 29,813 | 92 | Â | Â | Â | |
B2 | 29,202 | 33,822 | 86 | Â | Â | Â | |
C1 | 22,664 | 19,042 | 120 | 42,464 | 50,761 | 84 | |
C2 | 33,861 | 25,866 | 131 | 55,831 | 68,967 | 81 | |
Y4 Treatment 2 | A1 | 0 | 25,368 | Â | Â | Â | Â |
A2 | 16,309 | 21,528 | 76 | Â | Â | Â | |
B1 | 0 | 29,813 | Â | Â | Â | Â | |
B2 | 26,247 | 33,822 | 78 | Â | Â | Â | |
C1 | 0 | 19,042 | Â | Â | 50,761 | Â | |
C2 | 29,290 | 25,866 | 113 | 54,539 | 68,967 | 79 |